Literature DB >> 6810485

Cervical myelopathy due to dural compression in mucopolysaccharidosis.

H H Kaufman, H S Rosenberg, C I Scott, Y Y Lee, J L Pruessner, I J Butler.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6810485     DOI： 10.1016/s0090-3019(82)80004-9

Source DB:  PubMed          Journal:  Surg Neurol        ISSN： 0090-3019


× No keyword cloud information.
  6 in total

1.  Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients.

Authors:  Moin Vera; Steven Le; Shih-Hsin Kan; Hermes Garban; David Naylor; Anton Mlikotic; Ilkka Kaitila; Paul Harmatz; Agnes Chen; Patricia Dickson
Journal:  Pediatr Res       Date:  2013-09-03       Impact factor: 3.756

2.  Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.

Authors:  Patricia I Dickson; Stephen Hanson; Michael F McEntee; Charles H Vite; Carole A Vogler; Anton Mlikotic; Agnes H Chen; Katherine P Ponder; Mark E Haskins; Brigette L Tippin; Steven Q Le; Merry B Passage; Catalina Guerra; Ashley Dierenfeld; Jackie Jens; Elizabeth Snella; Shih-Hsin Kan; N Matthew Ellinwood
Journal:  Mol Genet Metab       Date:  2010-07-23       Impact factor: 4.797

3.  Mucopolysaccharidosis: thickening of dura mater at the craniocervical junction and other CT/MRI findings.

Authors:  A Taccone; P Tortori Donati; A Marzoli; A Dell'Acqua; R Gatti; D Leone
Journal:  Pediatr Radiol       Date:  1993

4.  Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product.

Authors:  Mark J Osborn; Ron T McElmurry; Brandon Peacock; Jakub Tolar; Bruce R Blazar
Journal:  Mol Ther       Date:  2008-06-03       Impact factor: 11.454

Review 5.  Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.

Authors:  Sun H Peck; Margret L Casal; Neil R Malhotra; Can Ficicioglu; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2016-06-04       Impact factor: 4.797

6.  alpha-L-iduronidase therapy for mucopolysaccharidosis type I.

Authors:  Jakub Tolar; Paul J Orchard
Journal:  Biologics       Date:  2008-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.